Fish Oil and Meloxicam, a caution.
High-dose fish oil may add mild antiplatelet activity to meloxicam's GI bleeding risk. Most randomized-trial data do not show major bleeding increases at usual omega-3 doses, but high-dose EPA/DHA and other bleeding risks can matter. The combination is more important with daily meloxicam, ulcer history, aspirin use, or planned procedures.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. High-dose fish oil may add mild antiplatelet activity to meloxicam's GI bleeding risk. Most randomized-trial data do not show major bleeding increases at usual omega-3 doses, but high-dose EPA/DHA and other bleeding risks can matter. The combination is more important with daily meloxicam, ulcer history, aspirin use, or planned procedures.
Mechanism. EPA and DHA can reduce platelet aggregation and alter thromboxane balance. Meloxicam can impair gastric mucosal protection through prostaglandin suppression, allowing platelet effects to become clinically relevant if GI injury occurs.
Recommendation. Use caution with high-dose fish oil while taking meloxicam daily. Tell your clinician before procedures and monitor for black stools, vomiting blood, nosebleeds, or unusual bruising.
Sources (2)
- Javaid M, Kadhim K, Bawamia B, Cartlidge T, Farag M, Alkhalil M. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc. 2024;13(10):e032390. PMID 38742535
- Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol. 2007;99(6A):35C-43C. PMID 17368277
Stack Score
How this pair moves the number.
Effect on the composite score
If both Fish Oil and Meloxicam are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.